NCT06102525 2025-09-05A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With GlioblastomaRznomics, Inc.Phase 1/2 Recruiting43 enrolled